Bristlecone Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,117
| Closed | -$223K | – | 292 |
|
|
2024
Q1 | $223K | Sell |
4,117
-270
| -6% | -$14.6K | 0.02% | 265 |
|
|
2023
Q4 | $225K | Sell |
4,387
-490
| -10% | -$25.1K | 0.02% | 253 |
|
|
2023
Q3 | $283K | Buy |
4,877
+8
| +0.2% | +$464 | 0.03% | 216 |
|
|
2023
Q2 | $311K | Buy |
4,869
+287
| +6% | +$18.4K | 0.03% | 215 |
|
|
2023
Q1 | $318K | Buy |
4,582
+506
| +12% | +$35.1K | 0.03% | 214 |
|
|
2022
Q4 | $293K | Buy |
4,076
+6
| +0.1% | +$432 | 0.04% | 210 |
|
|
2022
Q3 | $289K | Sell |
4,070
-53
| -1% | -$3.76K | 0.04% | 201 |
|
|
2022
Q2 | $317K | Buy |
4,123
+6
| +0.1% | +$461 | 0.04% | 198 |
|
|
2022
Q1 | $301K | Sell |
4,117
-220
| -5% | -$16.1K | 0.04% | 197 |
|
|
2021
Q4 | $270K | Buy |
4,337
+7
| +0.2% | +$436 | 0.03% | 198 |
|
|
2021
Q3 | $256K | Buy |
4,330
+800
| +23% | +$47.3K | 0.03% | 192 |
|
|
2021
Q2 | $236K | Buy |
3,530
+45
| +1% | +$3.01K | 0.03% | 198 |
|
|
2021
Q1 | $220K | Buy |
+3,485
| New | +$220K | 0.03% | 198 |
|
|
2020
Q1 | – | Sell |
-9,141
| Closed | -$587K | – | 158 |
|
|
2019
Q4 | $587K | Buy |
+9,141
| New | +$587K | 0.12% | 126 |
|
|
2019
Q3 | – | Sell |
-5,424
| Closed | -$246K | – | 145 |
|
|
2019
Q2 | $246K | Buy |
+5,424
| New | +$246K | 0.06% | 162 |
|
|
2016
Q2 | – | Sell |
-3,990
| Closed | -$255K | – | 140 |
|
|
2016
Q1 | $255K | Buy |
+3,990
| New | +$255K | 0.1% | 144 |
|